Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei-Yu Fang

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 25, 2003
[Isolation, identification and sequence analyses of dengue virus type 2 strain GD19/2001]Rui-wen Ren, Mei-yu Fang, Wen-yan Hong, et al.
Frontiers in Oncology|July 14, 2020
A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an <i>EGFR</i>-KDD and Response to AfatinibDong Chen, Xing-Liang Li, Biao Wu, et al.
Oncotargets and Therapy|July 20, 2017
Patients harboring <i>ALK</i> rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case reportYou-Cai Zhu, Xing-Hui Liao, Wen-Xian Wang, et al.
Translational Cancer Research|February 4, 2022
Association between <i>BRAF</i> mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective studyLei Lei, Wen-Xian Wang, You-Cai Zhu, et al.
Journal of Cancer|February 3, 2021
A real-world study in advanced non-small cell lung cancer with de novo brain metastasisLei Lei, Wen-Xian Wang, Dong Wang, et al.
Thoracic Cancer|August 29, 2017
Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature reviewChun-Wei Xu, Wen-Xian Wang, Rong-Fang Huang, et al.
Thoracic Cancer|June 8, 2017
Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancerChun-Wei Xu, Wen-Xian Wang, Mei-Juan Wu, et al.
Translational Oncology|December 28, 2019
A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS MutationsLei Lei, Wen-Xian Wang, Zong-Yang Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2020
A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinibHua-Fei Chen, Wen-Xian Wang, Chun-Wei Xu, et al.
Translational Oncology|June 4, 2020
Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non-Small Cell Lung Cancer and Response to EGFR TKIsChun-Wei Xu, Lei Lei, Wen-Xian Wang, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 25, 2003
[Isolation, identification and sequence analyses of dengue virus type 2 strain GD19/2001]Rui-wen Ren, Mei-yu Fang, Wen-yan Hong, et al.
Frontiers in Oncology|July 14, 2020
A Novel Oncogenic Driver in a Lung Adenocarcinoma Patient Harboring an <i>EGFR</i>-KDD and Response to AfatinibDong Chen, Xing-Liang Li, Biao Wu, et al.
Oncotargets and Therapy|July 20, 2017
Patients harboring <i>ALK</i> rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case reportYou-Cai Zhu, Xing-Hui Liao, Wen-Xian Wang, et al.
Translational Cancer Research|February 4, 2022
Association between <i>BRAF</i> mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective studyLei Lei, Wen-Xian Wang, You-Cai Zhu, et al.
Journal of Cancer|February 3, 2021
A real-world study in advanced non-small cell lung cancer with de novo brain metastasisLei Lei, Wen-Xian Wang, Dong Wang, et al.
Thoracic Cancer|August 29, 2017
Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature reviewChun-Wei Xu, Wen-Xian Wang, Rong-Fang Huang, et al.
Thoracic Cancer|June 8, 2017
Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancerChun-Wei Xu, Wen-Xian Wang, Mei-Juan Wu, et al.
Translational Oncology|December 28, 2019
A Real-World Study in Advanced Non-Small Cell Lung Cancer with KRAS MutationsLei Lei, Wen-Xian Wang, Zong-Yang Yu, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2020
A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinibHua-Fei Chen, Wen-Xian Wang, Chun-Wei Xu, et al.
Translational Oncology|June 4, 2020
Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non-Small Cell Lung Cancer and Response to EGFR TKIsChun-Wei Xu, Lei Lei, Wen-Xian Wang, et al.
Pageof 3